Europe - FRA:CVS - US1266501006 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to CVS.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2021-06-22 | Deutsche Bank | Maintains | Buy | 
| 2021-05-19 | BMO Capital | Maintains | Market Perform | 
| 2021-05-19 | Wolfe Research | Maintains | Outperform | 
| 2021-05-19 | Barclays | Maintains | Overweight | 
| 2021-05-19 | Wells Fargo | Initiate | Equal-Weight | 
| 2021-05-12 | Mizuho | Maintains | Buy | 
| 2021-05-06 | BMO Capital | Maintains | Market Perform | 
| 2021-05-06 | Credit Suisse | Maintains | Outperform | 
| 2021-05-05 | Raymond James | Maintains | Strong Buy | 
| 2021-04-14 | Truist Securities | Maintains | Buy | 
| 2021-04-14 | Morgan Stanley | Maintains | Overweight | 
| 2021-03-17 | Guggenheim | Downgrade | Buy -> Neutral | 
33 analysts have analysed CVS.DE and the average price target is 74.21 EUR. This implies a price increase of 9.25% is expected in the next year compared to the current price of 67.93.
The consensus rating for CVS HEALTH CORP (CVS.DE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.